SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors brace for the highly anticipated 80th event trigger in the REGAL Phase 3 trial, which will unblind the survival data and potentially catalyze a major acquisition. The community is intensely debating the stock's valuation, fueled by speculation regarding a multi-billion dollar buyout from big pharma players and significant upward pressure from elevated short borrow fees.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently driving intense community discussion following reports of a partnership with Shift4 Payments, which has sparked speculation about broader enterprise software adoption. While bulls emphasize the company's expanding role in AI-driven data analytics and government contracts, bears remain focused on valuation concerns and the stock's recent choppy price action within a wider consolidation phase.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing significant upward momentum as investors speculate on upcoming FDA peptide reviews and growth from new product integrations. The stock is currently a major focus for retail and institutional traders, with the community actively debating potential short-squeeze mechanics and the company's ability to maintain its recent price breakout.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is gaining traction as traders debate its potential for a rebound, with the community split between those accumulating in anticipation of ecosystem expansion and others dismissing the project as a speculative gamble. This heightened interest is largely driven by persistent discussions around the token's role within Japan's blockchain infrastructure and its ability to weather broader market volatility.

FreeCast, Inc. operates an online video streaming platform. Its cloud entertainment platform comprises the largest aggregated library of free and pay-per-view video-on-demand, streaming channels, live events, radio stations, music videos and online games. The company was founded by William A. Mobley, Jr. on June 21, 2011 and is headquartered in Orlando, FL.

Freecast Inc - Ordinary Shares - Class A

Freecast Inc

Freecast Inc. is experiencing extreme volatility and intense retail interest driven by a strategic reseller agreement with Starlink Business, fueling a massive short squeeze momentum. While retail bulls are aggressively targeting a continued rally and celebrating significant gains, community discourse remains sharply polarized between those betting on further upside potential and skeptics warning of imminent dilution risks and weak fundamentals.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is rallying as investors await critical Phase 3 VELA 52-week clinical data, which many anticipate will confirm the company's leading position in the Hidradenitis Suppurativa market. The community is heavily focused on the potential for a major valuation rerating or acquisition, with discussions centering on whether the upcoming trial results will trigger an M&A event or validate the asset's 'best-in-class' therapeutic potential.

BTQ Technologies Corp. engages in the business of post-quantum encryption. Its products include: QCIM, QSSN, OSS, QPoW, QRiNG. The company was founded by Nicolas Roussy Newton on Novemeber 23, 1983 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as investors debate the impact of the company's new C$150 million At-The-Market equity program, with some viewing the dilution as a necessary step to fund R&D while others fear further stock price collapse. The community remains deeply divided, balancing excitement over the company's post-quantum cryptography pilots and hardware development against concerns regarding its lack of revenue and the volatile public feud between company leadership.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is actively rallying behind the token's deflationary burn mechanism and its status as a multichain meme asset. Supporters are persistently accumulating tokens and building community sentiment, viewing it as a core project amidst broader market volatility.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and intense debate among investors as community members weigh the stock's long-term potential in the voice AI sector against concerns over insider share disposals, acquisition-related dilution, and short-seller pressure. While bulls point to recent industry recognition as an AI leader and a growing backlog of enterprise contracts as signs of an impending reversal, others remain skeptical, focusing on the company's path to profitability and lack of immediate catalysts to spark a sustained rally.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as community members weigh the impact of new Chinese export restrictions on critical rare earth elements against the company's long-term strategic role as a domestic supplier. Investors are actively debating the stock's technical price action and recent insider activity while gauging whether domestic policy tailwinds and defense-sector demand can offset current geopolitical headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oversold Conditions For Farmland Partners (FPI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Farmland Partners Q1 Earnings Call Highlights

Farmland Partners (NYSE:FPI) executives said first-quarter results were largely in line with internal expectations, while also addressing investor questions around the agricultural outlook amid...

Farmland Partners Inc. to Issue Quarterly Dividend of $0.09 (NYSE:FPI)

Farmland Partners Inc. (NYSE:FPI) declared a quarterly dividend on Tuesday, April 28th. Investors of record on Wednesday, July 1st will be given a dividend of 0.09 per share by the financial services...

Transcript: Farmland Partners Q1 2026 Earnings Conference Call

Farmland Partners (NYSE:FPI) Posts Earnings Results, Misses Expectations By $0.01 EPS

Farmland Partners (NYSE:FPI - Get Free Report) posted its earnings results on Wednesday. The financial services provider reported $0.01 earnings per share (EPS) for the quarter, missing the consensus...

Farmland Partners (NYSE:FPI) Releases FY 2026 Earnings Guidance

Farmland Partners (NYSE:FPI) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.300-0.350 for the period, compared to the consensus estimate of 0.310. The company also...

Farmland Partners (FPI) Q1 FFO and Revenues Beat Estimates

Farmland Partners (FPI) delivered FFO and revenue surprises of +25.00% and +15.06%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Farmland Partners Inc. Reports First Quarter 2026 Results

Farmland Partners Inc. (NYSE: FPI) (FPI or the Company) today reported financial results for the quarter ended March 31, 2026. Selected Highlights For the quarter ended March 31, 2026, the Company...

Farmland Partners (FPI) Expected to Announce Earnings on Wednesday

Farmland Partners (NYSE:FPI) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-farmland-partners-inc-stock...

Farmland Partners Inc. Announces Date for First Quarter 2026 Earnings Release and Conference Call

Farmland Partners Inc. (NYSE: FPI) (the Company) today announced it will release its financial results for the quarter ended March 31, 2026, after 5 p.m. (Eastern Time) on Wednesday, April 29, 2026...

Farmland Partners, Inc. is an internally managed real estate company. It engages in the business of owning and seeking to acquire high-quality farmland located in agricultural markets. The company was founded by Luca Fabbri on September 27, 2013 and is headquartered in Denver, CO.

Farmland Partners Inc

Farmland Partners Stock Gains After The Bell On Q4 Revenue Beat: But Retail’s Unfazed

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$9.76
Prev Close	$9.69
Open	$9.70
Dividend Yield	2.48%
50-Day Moving Average	$10.70
Beta	0.54
Avg. Volume	349,502.80
PE Ratio	18.41

52-Week High	$13.23
52-Week Low	$9.18
Market Capitalization	$425.7M
EPS (Annual)	$0.5618
Price to Book	0.92
Revenue Per Employee	$4.35M

FPIFarmland Partners Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FPI News